In this session the panelist will set the stage by discussing the Agricultural Improvement Act, more commonly known as the Farm Bill; specifically, the watershed moment in 2018 where industrial hemp was provided a federally legal pathway. The panel will discuss the unintended consequences created by the definition and function of weight allowance for delta-9 THC and its application to manufactured hemp derived products. The impacts of the definition on the hemp industry, the regulated marijuana industry and overall public health.
The Panelist will offer their predictions and recommendations on avenues to best address and elevate industrial hemp (grain, seed, fiber) from hemp grown for cannabinoids including perspectives on application farming versus manufacturing including potential modifications – increase to 1%, fit for purpose regulation, amongst others and possible exclusions within the 2023 Farm Bill actively being discussed by the 118th Congress. The discussion will highlight what ramifications such changes or the lack thereof could have on the Hemp and Regulated Marijuana industries including considering the FDA January 26th announcement regarding the status of CBD and other hemp cannabinoids and the ongoing evaluation of cannabis scheduling following President Biden’s presidential proclamation last year.